Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma

Clinical Trial ID NCT00712582

PubWeight™ 2.98‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00712582

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
2 FDG-PET/CT based response-adapted treatment. Cancer Imaging 2012 0.92
3 Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma. J Nucl Med 2015 0.80
Next 100